Aromatase imaging with [N-methyl-11C]vorozole PET in healthy men and women

Journal of Nuclear Medicine

Volumn 56, Issue 4, 2015, Pages 580-585

  Biegon, Anat ^a,b   Alexoff, David L ^b   Kim, Sung Won ^c   Logan, Jean ^d   Pareto, Deborah ^e   Schlyer, David ^b   Wang, Gene Jack ^c   Fowler, Joanna S ^b,f  

^a STONY BROOK UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f STONY BROOK UNIVERSITY   (United States)

Author keywords

Aromatase inhibitors; Biodistribution; Dosimetry; PET; Vorozole

Indexed keywords

AROMATASE; ESTROGEN; LETROZOLE; RADIOPHARMACEUTICAL AGENT; TESTOSTERONE; UNCLASSIFIED DRUG; VOROZOLE C 11; AROMATASE INHIBITOR; NITRILE; TRIAZOLE DERIVATIVE; VOROZOLE;

ADULT; AGED; AGING; ARTICLE; BIOACCUMULATION; BONE; BRAIN; BRAIN RADIOGRAPHY; BREAST; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; HEART; HUMAN; HUMAN EXPERIMENT; KIDNEY; LIVER; LUNG; MALE; MENSTRUAL CYCLE; MUSCLE; NORMAL HUMAN; OVARY; PELVIS RADIOGRAPHY; PENIS; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIOISOTOPE DISTRIBUTION; REPRODUCIBILITY; SMOKING; SPLEEN; TESTIS; TESTOSTERONE BLOOD LEVEL; THORAX RADIOGRAPHY; TISSUE LEVEL; UTERUS; AGE; CHEMISTRY; COMPUTER PROGRAM; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; DRUG EFFECTS; MIDDLE AGED; PROCEDURES; RADIATION RESPONSE; RADIOMETRY; SEX DIFFERENCE; WHOLE BODY RADIATION; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AROMATASE; AROMATASE INHIBITORS; DIAGNOSTIC IMAGING; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LIVER; MALE; MIDDLE AGED; NITRILES; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SEX FACTORS; SOFTWARE; TRIAZOLES; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 84928243108     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.150383     Document Type: Article

References (35)

1. Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab. 2002;3:561-597.
2. Simpson ER, Clyne C, Rubin G, et al. Aromatase: a brief overview. Annu Rev Physiol. 2002;64:93-127.
3. Roselli CE, Resko JA. Cytochrome P450 aromatase (CYP19) in the non-human primate brain: distribution, regulation, and functional significance. J Steroid Biochem Mol Biol. 2001;79:247-253.
4. 11C]vorozole. Synapse. 2010;64:801-807.
5. Biegon A, Fowler JS, Kim S-W, Logan J, Pareto D, Wang G-J. Distribution of aromatase in the human brain. In: Balthazart J, Ball JF, eds. Brain Aromatase, Estrogens and Behavior. New York, NY: Oxford University Press; 2012:89-99.
6. Roselli CE, Ellinwood WE, Resko JA. Regulation of brain aromatase activity in rats. Endocrinology. 1984;114:192-200.
7. Abdelgadir SE, Resko JA, Ojeda SR, Lephart ED, McPhaul MJ, Roselli CE. Androgens regulate aromatase cytochrome P450 messenger ribonucleic acid in rat brain. Endocrinology. 1994;135:395-401.
8. Garcia-Segura LM. Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol. 2008;20:705-712.
9. Saldanha CJ, Duncan KA, Walters BJ. Neuroprotective actions of brain aromatase. Front Neuroendocrinol. 2009;30:106-118.
10. Bulun SE, Simpson ER. Aromatase expression in women's cancers. Adv Exp Med Biol. 2008;630:112-132.
11. Fedele L, Somigliana E, Frontino G, Benaglia L, Vigano P. New drugs in development for the treatment of endometriosis. Expert Opin Investig Drugs. 2008;17:1187-1202.
12. Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Ann N Y Acad Sci. 2009;1155:194-205.
13. Miceli V, Cervello M, Azzolina A, Montalto G, Calabrò M, Carruba G. Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. Ann N Y Acad Sci. 2009;1155:252-256.
14. Vanden Bossche H, Willemsens G, Roels I, et al. R76713 and enantiomers: selective nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis. Biochem Pharmacol. 1990;40:1707-1718.
15. Cohen MH, Johnson JR, Li N, Chen G, Pazdur R. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Clin Cancer Res. 2002;8:665-669.
16. 11C] vorozole. Nucl Med Biol. 1998;25:497-501.
17. 11C-vorozole. Nucl Med Biol. 2006;33:599-605.
18. 11C-cyano] letrozole (Femara), an aromatase inhibitor drug. Nucl Med Biol. 2009;36:215-223.
19. 11C]vorozole, a radiotracer targeting cytochrome P450 aromatase. Nucl Med Biol. 2009;36:323-334.
20. 11C-methylated PET probe for aromatase imaging in the brain. J Nucl Med. 2014;55:852-857.
21. Alexoff DL, Shea C, Wolf AP, et al. Plasma input function determination for PET using a commercial laboratory robot. Nucl Med Biol. 1995;22:893-904.
22. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
23. 11C-vorozole binding in the human brain with PET. Mol Imaging. 2014;13:1-12.
24. Hiltunen M, Iivonen S, Soininen H. Aromatase enzyme and Alzheimer's disease. Minerva Endocrinol. 2006;31:61-73.
25. Li YF, Hu W, Fu SQ, Li JD, Liu JH, Kavanagh JJ. Aromatase inhibitors in ovarian cancer: is there a role? Int J Gynecol Cancer. 2008;18:600-614.
26. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol. 2003;86:219-224.
27. 18F-FDG endometrial and ovarian uptake in pre- and post-menopausal patients: assessment by PET/CT. J Nucl Med. 2004;45:266-271.
28. 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging. 2005;32:549-556.
29. 11C]orozole kinetics and effect of menstrual cycle. Mol Imaging. 2013;12:518-524.
30. Sasano H, Takahashi K, Satoh F, Nagura H, Harada N. Aromatase in the human central nervous system. Clin Endocrinol (Oxf). 1998;48:325-329.
31. Steckelbroeck S, Heidrich DD, Stoffel-Wagner B, et al. Characterization of aromatase cytochrome P450 activity in the human temporal lobe. J Clin Endocrinol Metab. 1999;84:2795-2801.
32. Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F, Klingmüller D. Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J Steroid Biochem Mol Biol. 1999;70:237-241.
33. Biegon A, Kim S-W, Logan J, Hooker JM, Muench L, Fowler JS. Nicotine blocks brain estrogen synthase (aromatase): in vivo PET studies in female baboons. Biol Psychiatry. 2010;67:774-777.
34. Golovine K, Schwerin M, Vanselow J. Three different promoters control expression of the aromatase cytochrome p450 gene (cyp19) in mouse gonads and brain. Biol Reprod. 2003;68:978-984.
35. Legro RS, Brzyski RG, Diamond MP, et al. NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371:119-129.